An approach to assessment of competitiveness of national pharmaceutical industry

Abstract

National pharmaceutical industry profileis an innovation-drivenindicator of any national economy and level of social assistance. Innovation in pharmaceutical industry associated withbranded pharmaceutical companieswhich make a great deal of investments in Research and Development (R&D). The world pharmaceutical market partitionby different regions was suggested referring to analytical information. It was made according to the factors such as different national pharmaceutical market conditions and its tendencies, governments’ patent protection, amount of consumers’ and government’s expenditures on the market. Component analysis, regression, and cluster analysis were implemented for estimation of competitiveness level of national pharmaceutical industries. According to the assessment countries’ rating was suggested, where the place of Russia was defined.